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-Alkyl -amino esters are available in high 5 
diastereoselectivity through a silicon-free Claisen enolate 
[3,3]-sigmatropic rearrangement of enamide esters. 
Optimisation studies have probed the crucial role of initial 
enolisation and the nature of the enamide N-centre. The 
demonstration of chirality transfer and the formation of -10 
proline systems, is also presented. 
Phosphatases are an important group of proteins with diverse 
biological roles.1 The exact pharmacological role played by the 
protein phosphatases in these biochemical processes in still 
unknown, partly due to a scarcity of selective inhibitors to act as 15 
biological probes.2 Accordingly, the development of efficient yet 
flexible syntheses of protein phosphatase inhibitors is of synthetic 
pertinence as crucial structure-activity relationship data for 
biological probing should therefore be attainable. 
 The natural cyclic peptide motuporin 13 (Figure 1) isolated 20 
form the marine sponge Theonella swinhoei (Gray) is a highly 
potent and selective protein phosphatase inhibitor. Motuporin 
inhibits protein phosphatase type 1 (PP1, IC50 < 1.0 nM) and 
displays cytotoxicity towards a number of human cancer cell 
lines.4 The biological activity of 1 is closely linked to the 25 
presence of the unusual -amino acid residue 
(2S,3S,8S,9S,4E,6E)-3-amino-9-methoxy-2,6,8-trimethyl-10-
phenyldecadenoic acid, ADDA, 2.5-6 This -amino acid residue is 
also found in the structurally related cyclic peptides nodularin 
and the microcystins.7 30 
 
Fig. 1 Motuporin and ADDA 
With a view to developing a flexible route to motuporin, we have 
examined a novel Ireland-Claisen8 substrate class9-10 assembled 
around a key enamide moiety (Scheme 1).11 On [3,3]-sigmatropic 35 
rearrangement of a silylketene acetal derived from such 
enamides, anti-2,3-amino esters are formed12 with the flexible 
synthetic handle of an N-allylic moiety also present. 
 
Scheme 1. Sensitivity of Diastereoselectivity to Substrate 40 
These initial studies uncovered a stark sensitivity of the levels of 
observed anti-diastereoselectivity to the nature of the substrate 
acyl fragment. Whilst poor levels of diastereocontrol were seen 
with propionate 3a, excellent diastereoselectivity was obtainable 
with phenylactetate substrate 3b (Scheme 1). 45 
 With the targets of motuporin and ADDA in mind, the need to 
improve the levels of diastereoselectivity seen in the 
rearrangement of propionate substrates was imperative. 
Accordingly, we have returned to examine this reaction in greater 
detail and report our findings in this Letter. However a more 50 
detailed level of optimisation failed to significantly improve upon 
the Ireland-Claisen reported in Scheme 1. Employment of 1.3 
equivalents of LiHMDS and Me3SiCl allowed for a small 
improvement in yield (72%) but with an identical level of 
diastereoselectivity (anti/syn=2:1; see Supporting Information for 55 
full attempts at re-optimisation). This optimisation study had 
examined variables such as the loading of base and silylation 
additive,13 nature of base, soft enolisation conditions14 and 
phosphorylative conditions,15 but this transformation was 
observed to be invariant. 60 
 Whilst this study did not appear to offer any particular hope for 
the development of a useful reaction, it did however mould our 
understanding of the problem at hand considerably. We initially 
hypothesised that increased stability of intermediate ester 
enolates and/or silylketene acetals offered by the presence of the 65 
conjugating phenyl group in 3b in contrast to propionate 3a was 
beneficial to the rearrangement of the enamide substrates. In the 
context of stabilising intermediate enolates, we became aware of 
Collum’s intriguing Si-free [3-3]-sigmatropic rearrangement of 
cinnamyl propionate 6 where a Li-enolate rearranges (Scheme 70 
2).16 
 
Scheme 2 Collum Si-Free Ester Enolate Claisen Rearrangement 
This protocol immediately offered itself as a potential solution to 
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the described synthetic problem. Using an adaptation of Collum’s 
conditions whereby the reaction was initiated at -95 °C, anti-4a 
was isolated after methylation in unexceptional yield however 
with excellent levels of diastereoselectivity (Entry 1, Table 1). 
Table 1 Silicon-Free Rearrangement Optimisation 5 
 
Entry M 8a (%)a dr (anti/syn) 8a 9a (%)a 
1 Li 46b >25:1 38 
2 Lic 21 >25:1 40 
4 Na 0 - 0 
5 K 0 - 0 
6 Lid 2 - 80 
7 Lie 3 - 80 
8 Lif 42g 2:1 0 
9 Li 0 - 0 
 
aAssayed by 1H NMR analysis of crude reaction mixture. bEster 4a 
isolated (45%) after treatment with CH2N2 in Et2O. 
 cLiHMDS (4 equiv), 
Et3N (40 equiv) used. 
dBase added to substrate and Me3SiCl (6 equiv). 
eMe3SiCl (6 equiv) added to base and substrate. 
fWarmed to quenching 10 
temperature of -10 °C. gStarting material 3a recovered (35%). hIntractable 
mixture formed. 
 
An increase in the loading of base proved detrimental with a 
lowering of 8a present in the crude mixture (Entry 2). The 15 
addition of silyl chloride to this protocol leads to an unfavourable 
outcome (Entries 6-7). The data presented suggests that a 
subsequent elimination of 2-oxazolidinone occurs after 
rearrangement. Furthermore, it had been noticed that a colour 
change occurred on warming to >-10 °C. When quenching a 20 
rearrangement at -10 °C a striking change in diastereoselectivity 
(Entry 8, dr=2:1 anti/syn) is observed. Therefore, we believe a 
kinetic resolution occurs with the syn-isomer preferentially 
eliminating to diene 9a after an initial poorly selective 
rearrangement. Further support for this hypothesis was obtained 25 
when isolated acid 8a was re-subjected to reaction conditions 
with dienyl acid 9a and an enrichment of the anti-diastereomer 
was observed (Scheme 3). The removal of the Lewis basic 
solvent THF from the system is seen to be important as shown by 
unsuccessfully attempting the rearrangement in this solvent (entry 30 
9). 
 
Scheme 3 Kinetic Resolution Mechanism for High Diastereocontrol in Si-
Free Rearrangement 
Whilst these studies were disappointing it in turn led us to 35 
examine the influence of the enamide nitrogen centre as this may 
affect leaving group ability and alter the electronic nature of the 
enamide. The preparation of alcohols 5b-e for subsequent 
acylation was attempted through a NaBH4 mediated reduction of 
the corresponding ketone. 40 
 
Fig. 2 Key enamido allylic alcohols studied 
We were unable to prepare 5b cleanly due to competing 
phthalimide carbonyl reduction. Enecarbamate alcohols 5c and 
5d proved particularly prone to dehydration, with crotonaldehyde 45 
and the parent N-H carbamate observed in crude 1H NMR 
analyses. In contrast, enesulfonamide 5e proved stable enough to 
convert via EDCI-mediated esterification to the corresponding 
propionate. 
 When conducting these Si-free Claisen rearrangements using 50 
the Collum protocol on the ester derivatives of 5c, we have 
observed a minor improvement in recovered yield on utilising a 
higher loading of LiHMDS and Et3N (4.5 and 45 equivalents 
respectively), possibly due to competitive N-allyl lithiation. 
These new conditions now lead to improved outcomes with high 55 
diastereoselectivity observed with no subsequent elimination 
(Entry 1, Table 2). The improvement when using the Collum-
based protocol for this N-allyl enamide is unambiguous when 
compared with the silylation protocol which offers poor yield and 
diastereoselectivity (Entry 2). 60 
Table 2 [3,3]-Sigmatropic Rearrangements of N-allyl enesulfonamides. 
 
Entry R 11 dra 12 13 
1 Me (10a) 51 (11a) >25:1 0 71 (13a) 
2b Me <5 1:1 53 - 
3 iPr (10b) 65 (11b) >25:1 0 86 (13b) 
4 Allyl (10c) 70 (11c) 10:1 0 - 
5 OBn (10d) 0 - 41 - 
6 Ph (10e) 30 (11d) >25:1 0 - 
7b Ph 67 >25:1 27 92 (13c) 
8b o-IC6H4 (10f) 67 (11e) >25:1 21 51
c (13d) 
9b p-OMe (10g) 73 (11f) >25:1 18 89 (13e) 
10b p-NO2 (10h) 40 (11g) 20:1 15 96 (13f) 
11b 
 
(10i) 
68 (11h) >25:1 22 83c (13g) 
12b 
 
(10j) 
55 (11i) >25:1 25 89 (13h) 
 
aanti/syn ratio measured by 1H NMR analysis of crude reaction mixtures. 
bLiHMDS (2.5 equiv), Me3SiCl (6 equiv), THF, -95 °C→20 °C.
 cRing 
closing diene metathesis conducted at 65 °C. 65 
 
On examining the substrate scope from the original 
communication, an improvement in dr is seen with the exception 
of the O-benzyl glycolate 10d. We feel the Si-free protocol for 
alkyl esters actually compliments a traditional silylation approach 70 
for arylacetate esters as we find a silylation approach is better for 
arylacetate substrates as seen when examining 10e (entries 6-7). 
It should be pointed out that methyl arylacetates 12 are also 
isolated and we believe this is due to methylation of the parent 
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acid after hydrolysis of unconverted substrate at the end of the 
reaction. It is worth commenting on the sensitivity of these 
enamide esters. The substrates under discussion will not 
withstand chromatography and even the nature of the acyl 
fragment can have a profound effect. We endeavoured to study an 5 
-amino ester substrate, with a view to synthesising ,-diamino 
acid systems. However, attempted carbodiimide coupling of 5e 
with N-phthaloyl glycine proved unsuccessful, even though we 
have published the synthesis and rearrangement of structurally 
homologous enol ether substrates.17 Furthermore, these previous 10 
studies also support our belief that the inability to form a 
rearranged product from 10d is not due to a lack of reactivity but 
due electronic issues with a substrate bearing multiple electron 
donating heteroatoms. 
 The amino dienes prepared through this sigmatropic approach 15 
lend themselves for subsequent elaboration, in particular a ring-
closing diene metathesis to pyrrolines.18 Accordingly, such a 
metathesis ring-closure was smoothly achieved using Grubb’s 1st 
generation in a number of instances (Table 2, Entries 1,3, 7-12). 
The products from these metatheses offer themselves as 20 
intriguing exocyclic carboxyl -prolines. The olefin synthetic 
handle and the excellent diastereocontrol suggest this strategy 
may offer some future synthetic value. For example, pyrroline 
13d was smoothly converted through an intramolecular Heck 
reaction, forming the tricyclic -amino ester 14 in good yield 25 
(Scheme 4).19 
 
Scheme 4 Heck Elaboration to Tricyclic -Proline Systems 
Finally, the development and examination of new enamide 
substrates has allowed us fulfil a long-term goal of preparing an 30 
enantioenriched substrate with a view to performing asymmetric 
versions of these enamide Ireland-Claisen rearrangements. The 
development of the N-allyl enamide class has allowed the 
transformation of commercial enantiopure butyn-2-ol through the 
protocol of Meyer.20 It is worth mentioning the non-trivial matter 35 
of cleanly forming such a substrate. However, we have 
ascertained that high levels of diastereo- (>25:1) and 
enantiocontrol (er >95:5) are achievable in this proof-of-concept 
study by the rearrangement of phenylacetate (S)-10f to (2R,3R)-
11f using the silylation protocol (Scheme 5). 40 
 
Scheme 5 Absolute Stereocontrol in [3,3]-Sigmatropic Rearrangement of 
Enamides 
Conclusions 45 
In conclusion, optimization studies have led to the development 
of new substrates for the [3,3]-sigmatropic rearrangements of 
enamido allylic esters. These developments include the use of N-
allyl enesulfonamides for the highly diastereoselective 
rearrangement of alkyl esters using a Si-free, enolate Claisen 50 
protocol. The electronic control offered by the new enamide has 
also provided suitable substrate stability to allow the 
rearrangement of enantiopure substrates. We are currently 
looking to expand the synthetic application of these -amino 
esters. 55 
Experimental procedures 
(E)-4-(N-Allyl-4-methylphenylsulfonamido)but-3-en-2-yl 
propionate (10a) 
To a solution of EDCi (0.54 g, 2.81 mmol) in CH2Cl2 (100 mL), 
was added triethylamine (0.39 mL, 2.81 mmol), DMAP (0.02 g, 60 
0.14 mmol) and propionic acid (0.22 mL, 2.81 mmol). This 
solution was cooled to 0 °C before adding 5e (0.40 g, 1.41 mmol) 
in CH2Cl2 (10 mL) and stirring for 15 h at room temperature. 
Citric acid (10%, 30 mL) was added and the organic layer 
separated before washing with further citric acid (10% 2x 30 65 
mL), NaHCO3 (sat. 3 x 30 mL), brine (30 mL). The organic layer 
was dried over MgSO4, filtered and solvent removed in vacuo to 
afford (E)-4-(N-allyl-4-methylphenylsulfonamido)but-3-en-2-yl 
propionate 10a as a yellow oil (0.40 g, 84%). FTIR (film/cm-1) 
max: 3082 (m), 3039 (m), 2980 (m), 2931 (m), 2861 (m), 1727 70 
(s), 1656 (s), 1597 (s); 1H NMR (500 MHz, (CD3)2CO)  1.10 (t, 
3H, J=7.6 Hz, CH3CH2-), 1.29 (d, 3H, J=6.6 Hz, CH3CH(CH-)O-
), 2.25 (q, 2H, J=7.6 Hz, CH3CH2-), 2.45 (s, 3H, -C6H4CH3), 3.96 
(qd, 2H, J=15.0, 5.4 Hz, -NCH2CHCH2), 4.80 (dd, 1H, J=14.2, 
6.6 Hz, -NCHCH-), 5.09–5.17 (m, 2H, CH2CHCH2N-), 5.34 75 
(app. quin, 1H, J=6.6 Hz, CH3CH(CH-)O-), 5.79 (ddt, 1H, 
J=17.0, 10.3, 5.4 Hz, -NCH2CHCH2), 6.96 (d, 1H, J=14.2 Hz, -
NCHCH-), 7.29 (app. d, 2H, J=7.6 Hz, ArH Ts), 7.65 (d, 2H, 
J=7.6 Hz, ArH Ts);13C NMR (125 MHz, (CDCl3) : 9.1, 21.0, 
21.5, 27.9, 48.0, 69.8, 110.1, 117.9, 127.0, 129.5, 129.8, 131.3, 80 
136.1, 143.9, 173.6; HRMS (ESI, +ve) m/z calcd. for 
C23H27NNaO4S  436.1558, found 436.1679 (M+Na)
+. 
 
(anti-E)-Methyl 3-(N-allyl-4-methylphenylsulfonamido)-2-
methylhex-4-enoate (11a) 85 
To a solution of LiHMDS (1M in toluene, 1.34 mL, 1.34 mmol) 
and triethylamine (1.81 mL, 13.4 mmol) at -95 °C was added 10a 
(0.10 g, 0.30 mmol) in toluene (1 mL) via syringe (4 mLh-1) 
down the side of the reaction vessel. The reaction was slowly 
warmed to room temperature over 1 hour before the addition of 90 
HCl (1 M)/brine (1:1, 5 mL). The organics were extracted with 
Et2O (5 x 15 mL) before immediate methylation with 
diazomethane (generated from N-nitrosomethyl urea in a 
diazomethane generator). Further purification by flash 
chromatography (EtOAc/petroleum ether 40 °C-60 95 
°C/triethylamine; 20:80:1→40:60:1) afforded (anti-E)-methyl 3-
(N-allyl-4-methylphenylsulfonamido)-2-methylhex-4-enoate 11a 
as a white solid (0.06 g, 55%, d.r. >25:1). M.p. 88–90 ˚C; FTIR 
(film/cm-1) max: 2966 (m), 2916 (m), 1735 (s), 165s (m); 
1H 
NMR (500 MHz, CDCl3)  1.06 (d, 3H, J=6.9 Hz), 1.51 (dd, 3H, 100 
J=6.4, 1.5 Hz), 2.39 (3H, s), 3.02 (ddt, 2H, J=10.1, 7.8, 6.9 Hz), 
2.83 (s, 3H), 3.69–3.85 (s, 2H), 4.27 (app. t, 1H, J=10.1 Hz), 
5.07–5.18 (m, 2H), 5.41 (ddq, 1H, J=15.1, 10.1, 1.5 Hz), 5.55 
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(dq, 1H, J=15.1, 6.4 Hz), 5.71 (ddt, 1H, J=17.3, 10.2, 6.5 Hz), 
7.26 (app. d, 2H, J=8.2 Hz), 7.69 (app. d, 2H, J=8.2 Hz);13C 
NMR (125 MHz, CDCl3) : 15.6, 17.7, 21.4, 43.4, 49.4, 51.7, 
64.1, 117.6, 126.2, 127.7, 129.1, 132.1, 135.3, 137.8, 142.9, 
175.0; HRMS (ESI, +ve) m/z calcd. for C18H25NO4S  352.1582, 5 
found 352.1577 (M+H)+. 
 
Methyl 2-(1-tosyl-2,5-dihydro-1H-pyrrol-2-yl)propanoate 
(13a) 
To a solution of 11a (0.02 g, 0.05 mmol) in CH2Cl2 (5 mL) was 10 
added Grubbs I catalyst (5 mol%) and stirred at room temperature 
for 6 h. When reaction was judged complete by TLC, the reaction 
was concentrated in vacuo and further purified by flash 
chromatography (EtOAc/petroleum ether 40 °C-60 °C; 
10:90→20:80) to afford 13a as a white solid (0.01 g, 79%).  M.p. 15 
95–97 ˚C; FTIR (film/cm-1) max: 2960 (m), 2928 (m), 2878 (m), 
1730 (s), 1597 (m); 1H NMR (500 MHz, CDCl3)  1.12 (d, 3H, 
J=7.1 Hz), 2.44 (s, 3H), 3.31 (qd, 1H, J=7.1, 3.96 Hz), 3.72 (s, 
3H), 4.06–4.19 (m, 2H), 4.84–4.89 (m, 1H), 5.55 (app dq, 1H, 
J=5.5, 2.2 Hz), 5.72 (app. dq, 1H, J=5.5, 2.2 Hz), 7.33 (app. d, 20 
2H, J=8.1 Hz), 7.74 (app. d, 2H, J=8.1 Hz);13C NMR (125 
MHz, CDCl3) : 10.1, 21.5, 43.9, 51.8, 56.1, 67.9, 126.5, 126.8, 
127.4, 129.8, 134.1, 143.6, 174.5; HRMS (ESI, +ve) m/z calcd. 
for C15H20NO4S  310.1130, found 310.1108 (M+H)
+. 
 25 
(E)-4-(N-Allyl-4-methylphenylsulfonamido)but-3-en-2-yl 2-(2-
iodophenyl)acetate (10f)  
To a solution of EDCi (0.54 g, 2.81 mmol) in CH2Cl2 (100 mL), 
was added triethylamine (0.39 mL, 2.81 mmol), DMAP (0.02 g, 
0.14 mmol), 2-iodo phenylacetic acid (0.74 g, 2.81 mmol). This 30 
solution was cooled to 0 °C before adding 5e (0.40 g, 1.41 mmol) 
in CH2Cl2 (20 mL) and stirring for 15 h at room temperature. 
Citric acid (10%, 30 mL) was added and the organic layer 
separated before washing with further citric acid (10% 2x 30 
mL), NaHCO3 (sat. 3 x 30 mL), brine (30 mL). The organic layer 35 
was dried over MgSO4, filtered and solvent removed in vacuo to 
afford 10f as a yellow oil (0.64 g, 86%). FTIR (film/cm-1) max: 
2978 (m), 2922 (m), 1727 (s), 1655 (s), 1596 (w); 1H NMR (500 
MHz, (CD3)2CO)  1.31 (d, 3H, J = 6.6 Hz), 2.44 (s, 3H), 3.77 
(app. d, 2H), 3.97–4.08 (m, 2H), 4.91 (dd, 1H, J = 14.2, 6.6 Hz), 40 
5.12 (app. dq, 1H, J = 10.4, 1.4 Hz), 5.20 (app. dq, 1H, J = 17.3, 
1.7 Hz), 5.39 (app. quin, 1H, J = 6.6 Hz), 5.65 (ddt, 1H, J = 17.3, 
10.4, 5.0 Hz), 7.00–7.08 (m, 2H), 7.35–7.43 (m, 4H), 7.72 (app. 
d, 2H, J=8.2 Hz), 7.88 (d, 1H, J=7.8 Hz);13C NMR (125 MHz, 
(CD3)2CO) : 20.4, 20.5, 46.0, 47.6, 70.6, 100.6, 109.9, 117.1, 45 
127.0, 128.4, 128.8, 129.8, 129.9, 131.0, 131.8, 136.4, 138.5, 
139.2, 144.0, 169.0; HRMS (ESI, +ve) m/z calcd. for 
C22H24INNaO4S  548.0368, found 548.0407 (M+Na)
+. 
 
(anti-E)-Methyl 3-(N-allyl-4-methylphenylsulfonamido)-2-(2-50 
iodophenyl) hex-4-enoate (11e) 
To a solution of LiHMDS (1M in THF, 0.34 mL, 0.34 mmol), 
TMSCl (0.10 mL, 1.57 mmol) at -95 °C was added 10f (0.07 g, 
0.26 mmol) in THF (0.7 mL) via syringe (4 mLh-1) down the side 
of the reaction vessel. The reaction was slowly warmed to room 55 
temperature over 1 hour before the addition of HCl (1 M)/brine 
(1:1, 5 mL). The organics were extracted with Et2O (5 x 15 mL) 
before immediate methylation with diazomethane (generated 
from N-nitrosomethyl urea in a diazomethane generator). Further 
purification by flash chromatography (EtOAc/petroleum ether 40 60 
°C-60 °C/triethylamine; 20:80:1→40:60:1) afforded (anti-E)-
methyl 3-(N-allyl-4-methylphenylsulfonamido)-2-(2-
iodophenyl)hex-4-enoate 11e as a white solid (0.05 g, 67%, d.r. 
>25:1). M.p. 97–99 ˚C; FTIR (film/cm-1) max: 3179 (w), 2953 
(m), 2922 (m), 1734 (s), 1597 (m); 1H NMR (500 MHz, CDCl3) 65 
 1.35 (d, 3H, J=6.5 Hz), 2.41 (s, 3H), 3.63 (s, 3H), 3.83 (app. d, 
1H, J=17.3, 6.7 Hz), 3.93 (app. d, 1H, J= 7.3, 6.7 Hz), 4.75 (d, 
1H, J=11.7 Hz), 4.91 (d, 1H, J=11.7 Hz), 5.14–5.23 (m, 2H), 
5.25–5.37 (m, 2H), 5.79 (ddt, 1H, J=17.0, 10.8, 6.7 Hz), 6.92 
(app. t, 1H, J=7.9 Hz), 7.26 (app. d, 2H, J = 8.7 Hz), 7.27–7.33 70 
(m, 1H), 7.51 (app d, 1H, J=7.9 Hz), 7.74 (app. d, 2H, J=8.7 Hz), 
7.82 (d, 1H, J=7.9 Hz);13C NMR (125 MHz, CDCl3) : 17.6, 
21.4, 49.2, 52.2, 57.8, 64.2, 118.1, 124.7, 127.9, 128.5, 128.9, 
129.0, 129.2, 129.3, 132.1, 135.0, 137.7, 138.9, 139.6, 143.1, 
171.8; HRMS (ESI, +ve) m/z calcd. for C25H32NO6S  474.1950,  75 
found  474.1948 (M+H)+. 
 
Methyl 2-(2-iodophenyl)-2-(1-tosyl-2,5-dihydro-1H-pyrrol-2-
yl)acetate (13d) 
To a solution of 11e (0.09 g, 0.17 mmol) in toluene (5 mL) was 80 
added Grubbs I catalyst (5 mol%) and stirred at 65 °C for 6 h. 
When reaction was judged complete by TLC, the reaction was 
concentrated in vacuo and further purified by flash 
chromatography (EtOAc/petroleum ether 40 °C-60 °C; 
10:90→20:80) to afford 13d as a white solid (0.04 g, 51%).  M.p. 85 
186–188 ˚C; FTIR (film/cm-1) max: 3026 (m), 2952 (m), 2878 
(m), 1728 (s), 1597 (m); 1H NMR (500 MHz, CDCl3)  2.42 (s, 
3H), 3.66–3.75 (m, 1H), 3.75 (s, 3H), 3.97 (app. dq, 1H J=15.7, 
1.9 Hz), 4.78 (d, 1H, J=5.6 Hz), 5.19–5.24 (m, 1H), 5.50–5.59 
(m, 2H), 6.95 (app. t, 1H, J=7.4 Hz), 7.24–7.34 (m, 4H), 7.73 90 
(app. d, 2H, J=8.3 Hz), 7.89 (app. d, 1H, J=7.4 Hz);13C NMR 
(125 MHz, CDCl3) : 21.5, 52.3, 55.5, 59.9, 68.7, 127.5, 127.6 
(x2), 127.7, 129.1, 129.7, 129.9, 134.2, 136.3, 138.0, 140.2, 
143.6, 172.2; HRMS (ESI, +ve) m/z calcd. for C22H21INO4S  
498.0235, found 498.0259 (M+H)+. 95 
 
anti-methyl 1-tosyl-1,2,8,8a-tetrahydroindeno[2,1-b]pyrrole-
8-carboxylate (14) 
To a solution of Pd(OAc)2 (3.00 mg, 0.01 mmol, 0.2 eq.), PPh3 
(3.67 mg, 0.01 mmol, 0.2 eq.), Ag2CO3 (29.1 mg, 0.11 mmol, 1.5 100 
eq.) in MeCN was added 11e (35.0 mg, 0.07 mmol, 1.0 eq.). The 
reaction mixture was refluxed for 4 h, concentrated in vacuo 
before being subjected to flash column chromatography using 
ethyl acetate/petroleum ether 40-60° (20:80) to yield 14 as an 
amorphous clear solid (22.0 mg, 84%). FTIR (film/cm-1) max: 105 
2958 (m), 2919 (m), 2849 (m), 1734 (s), 1597 (m); 1H NMR (500 
MHz, CD3Cl)  2.47 (s, 3H, -C6H4CH3), 3.80 (s, 3H, -CO2CH3), 
4.92 (br. d, 1H, J = 9.5 Hz, -NCHHCH-), 4.63 (br. s, 1H, -
CHCO2CH3), 4.90 (dd, 1H, J=9.5, 2.0 Hz, -NCHHCH-), 5.31 
(app. dd, 1H, J=4.1, 2.8 Hz, -NCH(CH-)CH-), 6.36 (app. dd, 1H, 110 
J=4.1, 2.8 Hz, -NCH2CH-), 7.10–7.15 (m, 1H, ArH), 7.23–7.27 
(m, 2H, ArH), 7.36 (app. d, 2H, J=8.2 Hz, ArH, Ts), 7.45–7.51 
(m, 1H, ArH), 7.75 (app. d, 2H, J=8.2 Hz, ArH, Ts); 13C NMR 
(125 MHz, CDCl3) : 21.6, 52.5, 54.5, 58.3, 66.1, 112.9, 125.1, 
126.1, 127.8, 127.9, 128.6, 129.9, 130.5, 132.9, 137.8, 142.9, 115 
144.2, 172.3; HRMS (ESI, +ve) m/z calcd. for C20H20N1O4S1  
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  5 
370.1148, found 370.1113 (M+H)+. 
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